NCT00177749View on ClinicalTrials.gov

Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095

PHASE4TerminatedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

November 30, 2006

Conditions

Fungal Infection

Interventions

DRUG

Posaconazole

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00177749 - Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 | Biotech Hunter | Biotech Hunter